Erschienen in:
29.10.2022 | Original Research
Borrmann Type Predicts Response to Preoperative Therapy in Advanced Gastric Cancer
verfasst von:
Yuki Hirata, Annamaria Agnes, Laura R. Prakash, Paul Mansfield, Brian D. Badgwell, Naruhiko Ikoma
Erschienen in:
Journal of Gastrointestinal Cancer
|
Ausgabe 3/2023
Einloggen, um Zugang zu erhalten
Abstract
Purpose
The Borrmann classification system is widely used to classify advanced gastric cancer (GC). No studies have focused on the relationship between Borrmann type and response to preoperative therapy.
Methods
Patients with advanced GC who received preoperative therapy followed by curative-intent gastrectomy from September 2016 through September 2021 were identified. Clinicopathologic characteristics were compared by Borrmann type. Logistic regression models were fit to analyze the relationship between Borrmann type and pCR rate.
Results
Of the 227 patients who underwent gastrectomy during the period studied, 73 had pretreatment endoscopic images available for analysis. We classified the tumors as follows: Borrmann type 1, 4 (6%); type 2, 17 (23%); type 3, 33 (45%); and type 4, 19 (26%). Nine patients (12%) achieved pCR; 6 of these (67%) had type 1/2 GC and 3 (33%) had type 3. Multivariable logistic regression showed that Borrmann type 3/4 was the only independent factor associated with pCR (odds ratio 0.12; p = 0.023), but 2-year overall survival rates did not differ by Borrmann type (p = 0.216).
Conclusion
Patients with Borrmann type 3/4 advanced GC have a lower likelihood of achieving pCR after preoperative therapy than those with type 1/2 GC. Determining the Borrmann type preoperatively can guide treatment decision-making.